欢迎访问上海芮晖化工科技有限公司官方网站!
咨询电话: +86-21-51623867|邮箱: sales@rechemscience.com
产品分类
联系我们
电话: +86-21-51623867   
  +86-15618786686
Email: sales@rechemscience.com
  info@rechemscience.com
QQ1:
QQ2:
1369748377
2295947952
Skype: rechem@outlook.com
首页 > 产品展示 > 中间体
目录号 产品名称 产品描述
R10157 AZD9291 Intermediate1 Osimertinib (AZD9291) is an oral, irreversible, and mutant-selective EGFR inhibi
R10158 AZD9291 Intermediate2 Osimertinib (AZD9291) is an oral, irreversible, and mutant-selective EGFR inhibi
R10261 CDC0032 Intermediate
R10275 Omarigliptin; MK3102 Intermediate1 Omarigliptin(MK-3102) is a potent, selective and long-acting DPP-4 inhibitor wit
R10276 Omarigliptin; MK3102 Intermediate2 Omarigliptin(MK-3102) is a potent, selective and long-acting DPP-4 inhibitor wit
R10277 AZD9291Intermediate3 Osimertinib (AZD9291) is an oral, irreversible, and mutant-selective EGFR inhibi
R10278 AZD9291Intermediate4 Osimertinib (AZD9291) is an oral, irreversible, and mutant-selective EGFR inhibi
R10279 AZD9291Intermediate5 Osimertinib (AZD9291) is an oral, irreversible, and mutant-selective EGFR inhibi
R10280 CAL101 Intermediate1 CAL-101 (Idelalisib, GS-1101) is a selective p110δ inhibitor with IC50 of 2.5 nM
R10281 CAL101 Intermediate2 CAL-101 (Idelalisib, GS-1101) is a selective p110δ inhibitor with IC50 of 2.5 nM
R10282 CAL101 Intermediate3 CAL-101 (Idelalisib, GS-1101) is a selective p110δ inhibitor with IC50 of 2.5 nM
R10284 Nintedanib; BIBF1120 Intermediate2 Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3,
R10285 Nintedanib; BIBF1120 Intermediate3 Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3,
R10286 Nintedanib; BIBF1120 Intermediate4 Nintedanib (BIBF 1120) is a potent triple angiokinase inhibitor for VEGFR1/2/3,
R10289 TR700; DA7157; Torezolid Intermediate1 Torezolid (TR-701; tedizolid) is a novel oxazolidinone for gram-positive infecti
R10290 TR700; DA7157; Torezolid Intermediate2 Torezolid (TR-701; tedizolid) is a novel oxazolidinone for gram-positive infecti
R10291 TR700; DA7157; Torezolid Intermediate3 Torezolid (TR-701; tedizolid) is a novel oxazolidinone for gram-positive infecti
R10292 TR700; DA7157; Torezolid Intermediate4 Torezolid (TR-701; tedizolid) is a novel oxazolidinone for gram-positive infecti
R10293 TR700; DA7157; Torezolid Intermediate5 Torezolid (TR-701; tedizolid) is a novel oxazolidinone for gram-positive infecti
R10294 TR700; DA7157; Torezolid Intermediate6 Torezolid (TR-701; tedizolid) is a novel oxazolidinone for gram-positive infecti
R10297 Afatinib BIBW2992 Intermediate1 Afatinib (BIBW2992) irreversibly inhibits EGFR/HER2 including EGFR(wt), EGFR(L85
R10298 Afatinib BIBW2992 Intermediate2 Afatinib (BIBW2992) irreversibly inhibits EGFR/HER2 including EGFR(wt), EGFR(L85
R10299 Afatinib BIBW2992 Intermediate3 Afatinib (BIBW2992) irreversibly inhibits EGFR/HER2 including EGFR(wt), EGFR(L85
R10300 Afatinib BIBW2992 Intermediate4 Afatinib (BIBW2992) irreversibly inhibits EGFR/HER2 including EGFR(wt), EGFR(L85
R10301 Afatinib BIBW2992 Intermediate5 Afatinib (BIBW2992) irreversibly inhibits EGFR/HER2 including EGFR(wt), EGFR(L85
第 1 页 / 共 19 页第一页上一页下一页最末页转到